Resistant Hypertension: Definition, Prevalence, and Cardiovascular Risk

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00159816%3A_____%2F13%3A00060746" target="_blank" >RIV/00159816:_____/13:00060746 - isvavai.cz</a>

Výsledek na webu

<a href="http://dx.doi.org/10.1007/978-88-470-5415-8_1" target="_blank" >http://dx.doi.org/10.1007/978-88-470-5415-8_1</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1007/978-88-470-5415-8_1" target="_blank" >10.1007/978-88-470-5415-8_1</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Resistant Hypertension: Definition, Prevalence, and Cardiovascular Risk

Popis výsledku v původním jazyce

There is no uniform definition of resistant hypertension. The 2007 ESH-ESC guidelines for management of arterial hypertension used the term resistant hypertension when a therapeutic plan that has included attention to lifestyle measures and prescriptionof at least three drugs (including a diuretic) at adequate doses has failed to lower systolic and diastolic BP. Many patients who present with resistant hypertension actually have pseudoresistant hypertension. The exact prevalence of resistant hypertension is unknown. However, small studies estimate the prevalence from 5% in general medical practice up to 50% in nephrology clinics. A Spanish Ambulatory Blood Pressure Monitoring (ABPM) Registry found a 12.2% prevalence of resistant hypertension in the treated hypertensive population. Cardiovascular risk and prognosis of patients with resistant hypertension has not been specifically evaluated. They usually have a long-standing history of poorly controlled hypertension, and commonly have a

Název v anglickém jazyce

Resistant Hypertension: Definition, Prevalence, and Cardiovascular Risk

Popis výsledku anglicky

There is no uniform definition of resistant hypertension. The 2007 ESH-ESC guidelines for management of arterial hypertension used the term resistant hypertension when a therapeutic plan that has included attention to lifestyle measures and prescriptionof at least three drugs (including a diuretic) at adequate doses has failed to lower systolic and diastolic BP. Many patients who present with resistant hypertension actually have pseudoresistant hypertension. The exact prevalence of resistant hypertension is unknown. However, small studies estimate the prevalence from 5% in general medical practice up to 50% in nephrology clinics. A Spanish Ambulatory Blood Pressure Monitoring (ABPM) Registry found a 12.2% prevalence of resistant hypertension in the treated hypertensive population. Cardiovascular risk and prognosis of patients with resistant hypertension has not been specifically evaluated. They usually have a long-standing history of poorly controlled hypertension, and commonly have a

Druh

C - Kapitola v odborné knize

CEP obor

FQ - Veřejné zdravotnictví, sociální lékařství

OECD FORD obor

—

Projekt

<a href="/cs/project/ED1.100%2F02%2F0123" target="_blank" >ED1.100/02/0123: Fakultní nemocnice u sv. Anny v Brně - Mezinárodní centrum klinického výzkumu (FNUSA - ICRC)</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2013

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název knihy nebo sborníku

Resistant Hypertension

ISBN

978-88-470-5414-1

Počet stran výsledku

9

Strana od-do

1-9

Počet stran knihy

195

Název nakladatele

Springer

Místo vydání

Milan

Kód UT WoS kapitoly

—